BioCentury
ARTICLE | Company News

ChromaVision, NewBiotics deal

November 11, 2002 8:00 AM UTC

CVSN will use its ACIS digital imaging system to analyze tissue samples from colon cancer patients in NewBiotics’ Phase I and II trials of Thymectacin. CVSN will receive a fee per specimen. ...